Officiële publicaties Innate Pharma

Aandelen

Beurs gesloten - Euronext Paris Andere beurzen 17:35:23 14-05-2024			Voorbeurs 07:49:37
2,325 ^EUR	+1,09%		2,333	+0,34%

15/04	Innate Pharma kondigt de voortgang aan van de door Sanofi-ontwikkelde NK Cell Engager SAR443579 / IPH6101 naar Fase 2 voor bloedkankerpatiënten	CI
10/04	Innate Pharma S.A. presenteert op AACR 2024 de preklinische werkzaamheid van haar pre-IND kandidaat IPH45, een nieuw Nectin-4 antilichaam geneesmiddelconjugaat	CI

Threshold crossings	21-10-22	CO
Provisional calendar	20-10-22	CO
Provisional calendar	20-10-22	CO
Slide show half-year results	15-09-22	CO
1st-half-year results	15-09-22	CO
1st-half-year results	15-09-22	CO
Half-year report	15-09-22	CO
Half-year report	15-09-22	CO
Monthly statement on voting rights	31-07-22	CO
Monthly statement on voting rights	31-07-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28-07-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	28-07-22	CO
Threshold crossings	18-07-22	CO
Corporate officers' Statement : Sale	29-06-22	CO
Corporate officers' Statement : Sale	17-06-22	CO
Corporate officers' Statement : Sale	14-06-22	CO
Corporate officers' Statement : Sale	14-06-22	CO
Corporate officers' Statement : Sale	14-06-22	CO
Slide show Q1	10-05-22	CO
1st quarter turnover	10-05-22	CO
1st quarter turnover	10-05-22	CO
Monthly statement on voting rights	30-04-22	CO
Monthly statement on voting rights	30-04-22	CO
Monthly statement on voting rights	28-02-22	CO
Monthly statement on voting rights	28-02-22	CO